Bruce J. Spohler
Analyst · KBW
Thank you, Rich. As Michael highlighted, we believe our 2013 portfolio activity has resulted in the lowest risk portfolio that we've had since our inception. We're pleased with the financial performance of our portfolio of companies, and their management teams are cautiously optimistic about their individual growth prospects. At 12/31, the weighted average yield on our income-producing investment portfolio was 11.3% and as Rich mentioned, the portfolio is 100% performing. The weighted average investment risk weighting of our total portfolio remained at approximately 2, when measured at fair market value at 12/31, based upon our 1 to 4 risk rating scale, with 1 representing the least amount of risk. At the end of Q4, our portfolio consisted of 40 portfolio companies operating in 26 industries. At fair value, 64% of the income-producing investments are floating rate, including Crystal Financial, whose portfolio consists entirely of senior secured loans. Approximately 69% of the portfolio is invested in secured assets. For the quarter, we originated just over $100 million of investments across 7 companies. When including Crystal Financial's Q4 investment activity, our originations totaled approximately $275 million. For the full year, including Crystal Financial, we originated just over $720 million of new investments, with approximately 98% invested in senior secured loans and substantially all of the income-producing investments were floating rate assets. Before I give an overview of Q4's portfolio activity, I'd like to spend a moment on some portfolio developments. As Michael mentioned, Rug Doctor, which was our one asset on nonaccrual at 9/30, completed its restructuring during Q4, with an outcome that caused us to return the asset to full accrual status. To support the restructuring, we made an approximately $9 million new investment in a cash-pay floating rate second lien security, along with our co-lenders. Our equity stake post the restructuring, combined with our other lenders, represents the majority of the equity account. We look forward to continuing to monitor and work with Rug Doctor to create value over time. As Michael mentioned, Crystal has performed well during our first year of ownership. As a reminder, this commercial finance company provides asset-based and other secured financing solutions to mid-market companies. At December 31, Crystal had a well diversified senior secured loan portfolio totaling approximately $465 million, consisted of 27 funded commitments to 23 borrowers. All of its investments are floating rate. The average exposure per issuer is approximately $20 million, thereby enhancing our diversification across Solar's portfolio. The weighted average yield on their loans is just in excess of 12.25%, and the portfolio was 100% performing at 12/31. At the end of Q4, total debt on Crystal's portfolio was approximately $200 million, representing a debt-to-equity ratio of approximately 0.7x. During the final quarter, we extended the duration, lowered the cost, and added a new lender to this credit facility. At 12/31, Solar had $75 million of available capital, subject to borrowing base limitations. Post year end, Crystal upsized its credit facility to $300 million, adding an additional $25 million of capacity. During Q4, our investment in Crystal paid Solar Capital a cash dividend of $8 million, which is the equivalent of an approximate 11.5% annualized cash-on-cash yield. And for the full year, Crystal paid Solar Capital a cash dividend of just under $32 million, which, again, equals a cash-on-cash yield of 11.5%. Let me now highlight a couple of our Q4 investments. Our most significant investment is a $44 million investment in second lien term loan for Tecomet, which is a leading manufacturer of medical device products, specifically artificial devices such as artificial knees. The transaction is part of a first lien, second lien loan package, which supported Genstar Capital's acquisition of the business. Our all-in yield on this investment is approximately 10.5%. We also funded approximately $8 million investment in the second lien term loan of Renaissance Learning, which is a provider of technology-enabled student assessment and school improvement programs. The company's products are focused predominantly on reading, as well as math and writing for K-12 aged students. Solar Senior Capital had been an investor in this company and had recently been repaid at par. Our familiarity with the company, as well as the sponsor, and its strong history of de-leveraging, was helpful during Solar Capital's due diligence process. In addition, we invested just over $9 million in the second lien term loan of HealthPort Technologies, which is a large provider of medical information exchange management services. The company is owned by ABRY Partners. Now let me touch on some of our Q4 repayments. Our $25 million investment in the second lien term loan of Endurance International Group was repaid at a premium to par. This latest repayment by Endurance created an IRR for us of 14% and represents the fifth time that Solar Capital's franchise has successfully invested in this company. Additionally, our $7 million investment in the senior secured notes of Good Sam Enterprises was repaid at a premium to par. We originally purchased these notes at a discount in the secondary market back in 2011, leveraging our prior experience with the credit under the name Affinity Group. Our IRR on this investment was approximately 19%. We were also redeemed out of our $15 million mezzanine notes in Crosman Corporation, owned by Wellspring, also at a premium to par. Our IRR in this investment, originally made in April 2011, is just under 17%. And in January, as Michael referenced, we were repaid on our $59 million subordinated loan to Earthbound Farms at a premium to par, which created an IRR of 17% when including our initial investment back in 2009, as well as our add-on investment in 2010. Now I'd like to turn the call back over to Michael.